InfoBionic MoMe ARC Virtual Cardiac Telemetry

InfoBionic.Ai calls itself the Virtual Cardiac Telemetry company and lists its address as Burleson, Texas. Its domain infobionic.com now redirects to infobionic.ai. The company builds remote cardiac monitoring for hospital-to-home and value-based care.

MoMe ARC is the core monitoring platform, used with interchangeable MoMe Sensors that are matched to patient acuity, a MoMe Gateway and AI-enabled MoMe Solutions that surface relevant data and flag anomalies. MoMe Analytics adds business intelligence for cardiac care, and the MoMe ARC Patch received FDA clearance announced in August 2025.

• MoMe ARC platform: remote cardiac monitoring core with configurable alerts.
• MoMe Sensors: interchangeable, tiered biosensor lead sets matched to patient acuity.
• MoMe ARC Patch: patch form factor with FDA clearance announced August 2025.
• AI analysis: MoMe Solutions flags anomalies including atrial fibrillation.
• MoMe Gateway: connects sensors to the platform.
• MoMe Analytics: business intelligence for cardiac care programs.

Hospitals extending telemetry to general wards without dedicated monitored beds. Cardiology clinics running arrhythmia evaluation and atrial fibrillation follow-up at home. Hospital networks coordinating hospital-to-home transitions for cardiac patients.

Sensor pods can be matched to patient acuity, from high-acuity diagnostics to on-the-go monitoring. AI-powered analysis surfaces relevant data and flags anomalies for staff. Configurable, hospital-grade monitoring can run from remote locations. Analytics help cardiology programs review their own performance.

Hospitals and cardiology groups are moving from wired telemetry and short Holter studies to virtual cardiac telemetry that follows patients from hospital to home. In Vietnam and Southeast Asia, shortage of monitored beds and cardiology staff outside large cities supports demand for remote telemetry with AI triage.

Address listed as 820 SW Wilshire Blvd, Burleson, TX. The website lists a GSA Schedule listing, an ANAB-accredited ISO 13485 certificate and 16 U.S. patents with one application pending. Domain moved from infobionic.com to infobionic.ai. Founding year not stated.